Leveraging artificial intelligence to predict ERG gene fusion status in prostate cancer

by Cao, X., Cheng, J., Chinnaiyan, A., Chinnaiyan, A.M, Dadhania, V., Dhanasekaran, S.M, Gonzalez, D., Mannan, R., Mehra, R., Morgan, T.M, Pantanowitz, L., Reichert, Z.R, Spratt, D.E, Wang, X., Yousif, M.
Published 2022

CRISPRs in the human genome are differentially expressed between malignant and normal adjacent to tumor tissue

by Brouwer, R.W.W, Chinnaiyan, A.M, Fijneman, R.J.A, Halimi, Y., Hoogstrate, Y., Janssen, B., Jenster, G., Komor, M.A, Louwen, R., Martens-Uzunova, E.S, Niknafs, Y.S, Saha, C., Strepis, N., Stubbs, A., Swagemakers, S.M.A, Tanmoy, A.M, van de Geer, W.S, van der Spek, P.J, van IJcken, W.F.J, van Riet, J., Voogd, S.
Published 2022

Collision tumors revealed by prospectively assessing subtype-defining molecular alterations in 904 individual prostate cancer foci

by Alnajar, H., Axcrona, K., Axcrona, U., Barbieri, C.E, Beg, S., Bhinder, B., Blattner-Johnson, M., Bogaard, M., Cai, P.Y, Calagua, C., Chinnaiyan, A.M, Croyle, J.A, Elemento, O., Fontugne, J., Johannessen, B., MacDonald, T.Y, Mosquera, J.M, Noorzad, Z., Park, K., Rubin, M.A, Sailer, V., Sanda, M.G, Scherr, D.S, Siddiqui, J., Skotheim, R.I, Ye, H.
Published 2022